 |
 |
Current Science, Inc.
400 Market Street
Suite 700
Philadelphia, PA 19106 |
| Tel: |
1-800-427-1796 (U.S.)
(215) 574-2266 |
| Fax: |
(215) 574-2225 |
|
|
|
|
|
| Volume 5, Issue 3: August 2006 |
|
| Web Alert |
|
| This alert contains detailed reviews of Web sites concerning hepatitis. |
|
|
|
|
| Full Text • PDF • pp. 75-76 |
|
|
|
Hepatitis C: Current and Future Therapies
Ira M. Jacobson, section editor |
|
| 1. |
|
The Impact of Race and Ethnicity on the Treatment of Hepatitis C Disease |
|
|
|
|
|
Carla W. Brady and
Andrew J. Muir
|
|
|
|
|
|
Abstract • Full Text • PDF • pp. 79-85 |
|
|
|
|
|
| 2. |
|
Fibrosis Markers in Hepatitis C |
|
|
|
|
|
Carla W. Brady,
John G. McHutchison, and
Keyur Patel
|
|
|
|
|
|
Abstract • Full Text • PDF • pp. 86-93 |
|
|
|
|
|
| 3. |
|
Antifibrotic Targets and Therapyin HCV |
|
|
|
|
|
Efsevia Albanis and
Scott L. Friedman
|
|
|
|
|
|
Abstract • Full Text • PDF • pp. 94-100 |
|
|
|
|
|
| 4. |
|
Treatment of HCV Infection in Patients with Renal Failure |
|
|
|
|
|
Suphamai Bunnapradist,
Fabrizio Fabrizi, and
Paul Martin
|
|
|
|
|
|
Abstract • Full Text • PDF • pp. 101-107 |
|
|
|
|
|
| 5. |
|
Treatment of Nonresponders toStandard Hepatitis C Therapy |
|
|
|
|
|
Maya Gambarin-Gelwan and
Ira M. Jacobson
|
|
|
|
|
|
Abstract • Full Text • PDF • pp. 108-113 |
|
|
|
|
|
| 6. |
|
Chronic Hepatitis C:Treatment of Pegylated Interferon/Ribavirin Nonresponders |
|
|
|
|
|
|
|
|
|
|
|
Abstract • Full Text • PDF • p. 114 |
|
|
|
|
|
| 7. |
|
Future Therapies for Hepatitis C |
|
|
|
|
|
Asim S. Khokhar,
Valerie Byrnes, and
Nezam H. Afdhal
|
|
|
|
|
|
Abstract • Full Text • PDF • pp. 121-128 |
|
|
|
|
|
|
|
